Success Metrics

Clinical Success Rate

75.0%

Based on 3 completed trials

Completion Rate

75%(3/4)

Active Trials

0(0%)

Results Posted

100%(3 trials)

Terminated

1(25%)

Phase Distribution

Ph phase_1

25%

Ph phase_3

75%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution4 total trials

Phase 1Safety & dosage

1(25.0%)

Phase 3Large-scale testing

3(75.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(3)

Terminated(1)

Detailed Status

Completed3

Terminated1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

75.0%

Most Advanced

Phase 3

Trials by Phase

Phase 11 (25.0%)

Phase 33 (75.0%)

Trials by Status

terminated125%

completed375%

Recent Activity

0 active trials

Showing 4 of 4

terminatedphase_1

Positron Emission Tomography (PET) Study in Patients With Alzheimer's Disease

NCT03307993

completedphase_3

Idalopirdine in Patients With Mild-moderate Alzheimer's Disease Treated With Donepezil

NCT02006641

completedphase_3

Study of Idalopirdine in Patients With Mild - Moderate Alzheimer's Disease Treated With an Acetylcholinesterase Inhibitor

NCT02006654

completedphase_3

Study of Idalopirdine in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil

NCT01955161

Clinical Trials (4)

Showing 4 of 4 trials

NCT03307993Phase 1

Positron Emission Tomography (PET) Study in Patients With Alzheimer's Disease

Terminated

NCT02006641Phase 3

Idalopirdine in Patients With Mild-moderate Alzheimer's Disease Treated With Donepezil

Completed

NCT02006654Phase 3

Study of Idalopirdine in Patients With Mild - Moderate Alzheimer's Disease Treated With an Acetylcholinesterase Inhibitor

Completed

NCT01955161Phase 3

Study of Idalopirdine in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil

Completed

All 4 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 4